U
CHTP

UBS’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

UBS’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-70,671
Closed -$390K – 11289
2014
Q1 		$390K Sell
70,671
-45,226
-39% -$227K ﹤0.01% 4511
2013
Q4 		$514K Buy
115,897
+75,041
+184% +$254K ﹤0.01% 4305
2013
Q3 		$122K Sell
40,856
-118,143
-74% -$339K ﹤0.01% 5796
2013
Q2 		$366K Buy
+158,999
New +$321K ﹤0.01% 4421

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

UBS's CHTP Position: Q2 2014 in Review

UBS sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 70,671 shares — an estimated $390K sold.

UBS first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $514K in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • UBS reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • UBS sold 70,671 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $390K.
  • UBS first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • UBS's CHELSEA THERAPEUTICS INT'L LTD position peaked at $514K in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.